THYROCARE

Thyrocare Technologies Share PriceThyrocare Technologies

₹429.85
8.6 (2.04%)
As on 01 April, 2023 | 16:47 BSE: 539871 NSE: THYROCARE

Thyrocare Technologies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Thyrocare Technologies

Start SIP

Thyrocare Technologies Share Price

  • Over 1 Month -4.85%
  • Over 3 Month -30.52%
  • Over 6 Month -38.62%
  • Over 1 Year -44.56%

Thyrocare Technologies Key Statistics

P/E Ratio 31.1
PEG Ratio -0.5
Market Cap Cr 2,275
Price to Book Ratio 4.3
EPS 28.1
Dividend 3.5
Relative Strength Index 31.14
Money Flow Index 22.85
MACD Signal -14.94
Average True Range 16.72

Thyrocare Technologies Investment Rating

  • Master Rating:
  • Thyrocare Technologies has an operating revenue of Rs. 521.35 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 39% is great, ROE of 33% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 40 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Services and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Thyrocare Technologies Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 117125119123
Operating Expenses Qtr Cr 91968587
Operating Profit Qtr Cr 26303437
Depreciation Qtr Cr 9889
Interest Qtr Cr 1111
Tax Qtr Cr 5869
Net Profit Qtr Cr 13142020

Thyrocare Technologies Technicals

EMA & SMA

Current Price
₹429.85
8.6 (2.04%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 448.69
  • 50 Day
  • 484.3
  • 100 Day
  • 532.95
  • 200 Day
  • 609.55
  • 20 Day
  • 451.67
  • 50 Day
  • 482.09
  • 100 Day
  • 550.27
  • 200 Day
  • 599.71

Thyrocare Technologies Resistance and Support

PIVOT
₹422.22
Resistance
First Resistance 429.04
Second Resistance 436.82
Third Resistance 443.64
RSI 31.14
MFI 22.85
MACD Single Line -14.94
MACD -16.37
Support
First Resistance 414.44
Second Resistance 407.62
Third Resistance 399.84

Thyrocare Technologies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 100,185 6,704,380 66.92
Week 142,344 5,614,038 39.44
1 Month 79,350 3,702,466 46.66
6 Month 152,010 3,924,904 25.82

Thyrocare Technologies Result Highlights

Thyrocare Technologies Synopsis

NSE-Medical-Services

Thyrocare Tech. is involved in the business activities of Activities of independent diagnostic/pathological laboratories. Company’s Total Operating Revenue is Rs. 561.53 Cr. and Equity Capital is Rs. 52.90 Cr. for the Year ended 31/03/2022. Thyrocare Technologies Ltd. is a Public Limited Listed company incorporated on 28/01/2000 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85110MH2000PLC123882 and registration number is 123882.
Market Cap 2,275
Sales 485
Shares in Float 1.53
No of funds 76
Yield 3.49
Book Value 4.37
U/D Vol ratio 0.4
LTDebt / Equity
Alpha -0.21
Beta 0.39

Thyrocare Technologies

Owner NameDec-22Sep-22Jun-22
Promoters 71.14%71.14%71.18%
Mutual Funds 7.3%6.81%4.72%
Insurance Companies 1.08%1.85%1.96%
Foreign Portfolio Investors 10.13%10.42%12.82%
Financial Institutions/ Banks
Individual Investors 8.07%7.28%6.72%
Others 2.28%2.5%2.6%

Thyrocare Technologies Management

Name Designation
Mr. Rahul Guha Managing Director & CEO
Mr. Dharmil Sheth Non Executive Director
Mr. Hardik Dedhia Non Executive Director
Mr. Dhaval Shah Non Executive Director
Mr. Gopalkrishna Shivram Hegde Independent Director
Mr. Vishwas Kulkarni Independent Director
Dr. Neetin S Desai Independent Director
Dr. Indumati Gopinathan Independent Director

Thyrocare Technologies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Thyrocare Technologies MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23910
Nippon India Pharma Fund - Growth 4268
UTI Dividend Yield Fund Regular Plan Growth 2787
Nippon India Retirement Fund - Wealth Creation Scheme - Regular Growth 2233
Union Small Cap Fund Regular Growth 1401

Thyrocare Technologies FAQs

What is Share Price of Thyrocare Technologies ?

Thyrocare Technologies share price is ₹429 As on 01 April, 2023 | 16:33

What is the Market Cap of Thyrocare Technologies ?

The Market Cap of Thyrocare Technologies is ₹2275.2 Cr As on 01 April, 2023 | 16:33

What is the P/E ratio of Thyrocare Technologies ?

The P/E ratio of Thyrocare Technologies is 31.1 As on 01 April, 2023 | 16:33

What is the PB ratio of Thyrocare Technologies ?

The PB ratio of Thyrocare Technologies is 4.3 As on 01 April, 2023 | 16:33

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number